Posted on February 28, 2012

Oncologic Drugs Advisory Committee

• Minutes for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 71KB)
• 2012 Meeting Materials, Oncologic Drugs Advisory Committee
• Minutes for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 27KB)

Endocrinologic and Metabolic Drugs Advisory Committee

• Briefing Information for the July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee
• Errata (2) to the FDA Briefing Information for the July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (PDF – 9KB)  (PDF - 8KB)

Advisory Committee Calendar

• April 2, 2012: Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee Meeting Announcement

Nonprescription Drugs Advisory Committee

• 2012 Meeting Materials, Nonprescription Drugs Advisory Committee

Anti-Infective Drugs Advisory Committee

• 2012 Meeting Materials, Anti-Infective Drugs Advisory Committee

Cardiovascular and Renal Drugs Advisory Committee

• 2012 Meeting Materials, Cardiovascular and Renal Drugs Advisory Committee

Advisory Committee Calendar

• March 27, 2012: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement

Pharmaceutical Science and Clinical Pharmacology Advisory Committee

• Vinks_Disclosure Document for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-14KB)  (PDF - 19KB)
• Mager_Disclosure Document for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-14KB)  (PDF - 19KB)
• 18 U.S.C. 208(a) and 712(c)(2)(B) Waivers for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-22KB)  (PDF - 34KB)
• Capparelli_Disclosure Document for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-14KB)  (PDF - 19KB)
• 18 U.S.C. 208(a) and 712(c)(2)(B) Waivers for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-157KB)  (PDF - 168KB)
• Disclosure Document for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-14KB)  (PDF - 19KB)
• Waivers for Conflicts of Interest for the March 14, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology
• 18 U.S.C. 208(a) and 712(c)(2)(B) Waivers for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-263KB)  (PDF - 266KB)
• 18 U.S.C. 208(a) and 712(c)(2)(B) Waivers for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-249KB)  (PDF - 252KB)
• 2012 Meeting Materials, Pharmaceutical Science and Clinical Pharmacology Advisory Committee

Posted on February 27, 2012

Advisory Committee Calendar

• March 1-2, 2012 - Tobacco Products Scientific Advisory Committee Meeting Announcement

Gastrointestinal Drugs Advisory Committee

• Waivers for Conflicts of Interest for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee
• Disclosure Document for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-16KB)  (PDF - 13KB)
• 18 U.S.C. 208(a) and 712(c)(2)(B) Waivers for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-509KB)  (PDF - 512KB)

Posted on February 24, 2012

Advisory Committee Calendar

• April 11-12, 2012: Radiological Devices Panel of the Medical Devices Advisory Committee Meeting Announcement

Posted on February 23, 2012

Dermatologic and Ophthalmic Drugs Advisory Committee

• 2012 Meeting Materials, Dermatologic and Ophthalmic Drugs Advisory Committee
• Committee Roster for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee  (PDF - 20KB)
• Draft Meeting Roster for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee  (PDF - 29KB)
• Draft Questions for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee  (PDF - 19KB)
• Draft Agenda for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee  (PDF - 18KB)

Nonprescription Drugs Advisory Committee

• Nonprescription Drugs Advisory Committee

Peripheral and Central Nervous System Drugs Advisory Committee

• Peripheral and Central Nervous System Drugs Advisory Committee

Posted on February 21, 2012

Oncologic Drugs Advisory Committee

• Webcast Information for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 29KB)
• Webcast Information for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 28KB)
• Slides for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee
• Eisai Backup Presentations for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 237KB)  (PDF - 237KB)
• Eisai Main Presentations for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 1.13MB)  (PDF - 1.1MB)
• FDA Backup Presentations for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 19KB)  (PDF - 18KB)
• FDA Main Presentations for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 539KB)  (PDF - 273KB)
• Final Meeting Roster for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 19KB)
• Final Questions for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 42KB)
• Final Agenda for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 17KB)
• Slides for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee
• Amgen Presentations for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 1.52MB)  (PDF - 1.5MB)
• FDA Backup Presentations for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 18KB)  (PDF - 14KB)
• FDA Main Presentations for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 548KB)  (PDF - 516KB)
• Final Meeting Roster for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 17KB)
• Final Questions for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 15KB)
• Final Agenda for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 15KB)

Cardiovascular and Renal Drugs Advisory Committee

• Briefing Information for the February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee